Inventor · disambiguated record
Jerome B. Zeldis
Also filed as: ZELDIS JEROME · ZELDIS JEROME B
65 granted patents·82 pending applications·2,157 citations·filing 1988–2020
99Inventor score
Top patents by PatentIndex Score
147 records- 0199US9101622B2Methods for treating newly diagnosed multiple myeloma 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with dexamethasoneCELGENE CORP·Filed 2014·Granted Aug 11, 2015·60 cites·25 claims
- 0299US9101621B2Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantationCELGENE CORP·Filed 2014·Granted Aug 11, 2015·744 cites·21 claims
- 0399US8735428B2Methods for treating multiple myeloma with 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dioneCELGENE CORP·Filed 2013·Granted May 27, 2014·37 cites·27 claims
- 0499US8673939B2Methods for treating multiple myeloma with 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dioneCELGENE CORP·Filed 2013·Granted Mar 18, 2014·41 cites·35 claims
- 0599US8198306B2Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a proteasome inhibitorZELDIS JEROME B·Filed 2009·Granted Jun 12, 2012·54 cites·22 claims
- 0699US8198262B2Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dioneZELDIS JEROME B·Filed 2008·Granted Jun 12, 2012·65 cites·29 claims
- 0799US7468363B2Methods for treatment of cancers using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dioneCELGENE CORP·Filed 2005·Granted Dec 23, 2008·79 cites·24 claims
- 0899US7393862B2Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemiasCELGENE CORP·Filed 2005·Granted Jul 1, 2008·100 cites·25 claims
- 0998US8648095B2Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with proteasome inhibitorZELDIS JEROME B·Filed 2012·Granted Feb 11, 2014·32 cites·25 claims
- 1098US8530498B1Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dioneCELGENE CORP·Filed 2013·Granted Sep 10, 2013·32 cites·13 claims
- 1198US8207200B2Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroindol-2-yl)-piperidine-2,6-dione follow by autologous stem cell transplantationZELDIS JEROME B·Filed 2008·Granted Jun 26, 2012·28 cites·14 claims
- 1298US8188118B2Method for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with antibodiesZELDIS JEROME B·Filed 2009·Granted May 29, 2012·34 cites·25 claims
- 1398US7968569B2Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dioneCELGENE CORP·Filed 2003·Granted Jun 28, 2011·87 cites·15 claims
- 1498US7863297B2Methods of using 4-(amino)-2-(2,6-dioxo(3-piperidly))-isoindoline-3-dione for the treatment of myelodysplastic syndromesCELGENE CORP·Filed 2007·Granted Jan 4, 2011·41 cites·17 claims
- 1598US7189740B2Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromesCELGENE CORP·Filed 2003·Granted Mar 13, 2007·137 cites·34 claims
- 1697US9056120B2Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidineCELGENE CORP·Filed 2013·Granted Jun 16, 2015·19 cites·53 claims
- 1797US8759375B2Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione in combination with proteasome inhibitorCELGENE CORP·Filed 2013·Granted Jun 24, 2014·18 cites·37 claims
- 1896US8722647B2Methods for treating amyloidosis using 4-(amino)-2-(2,6-Dioxo(3-piperidyl))- isoindoline-1,3-dioneZELDIS JEROME B·Filed 2012·Granted May 13, 2014·14 cites·29 claims
- 1996US7393863B2Methods of using N-{[2-(2,6-dioxo(3-piperidyl)-1,3-dioxoisoindolin-4-yl]methyl}cyclopropyl-carboxamide for the treatment and management of myelodysplastic syndromesCELGENE CORP·Filed 2007·Granted Jul 1, 2008·30 cites·36 claims
- 2095US8741929B2Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of mantle cell lymphomasZELDIS JEROME B·Filed 2009·Granted Jun 3, 2014·21 cites·24 claims
- 2195US6255325B1Chronic, bolus administration of D-threo methylphenidateCELGENE CORP·Filed 1999·Granted Jul 3, 2001·53 cites·1 claims
- 2294US8492406B2Methods for treatment of follicular lymphoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dioneZELDIS JEROME B·Filed 2010·Granted Jul 23, 2013·10 cites·33 claims
- 2394US6602887B2Chronic, bolus administration of D-threo methylphenidateCELGENE CORP·Filed 2001·Granted Aug 5, 2003·28 cites·8 claims
- 2493US8722705B2Methods for treating diffuse large B-cell lymphoma with 3-(4-amino-1-OXO-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with second active agentsCELGENE CORP·Filed 2013·Granted May 13, 2014·7 cites·21 claims
- 2593US8410136B2Methods for treatment of hepatocellular carcinoma using 3-(4-amino-1-OXO-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dioneZELDIS JEROME B·Filed 2010·Granted Apr 2, 2013·9 cites·28 claims
- 2693US7115631B2Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidateCELGENE CORP·Filed 2002·Granted Oct 3, 2006·39 cites·56 claims
- 2792US9050324B2Methods for treating amyloidosis with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dioneCELGENE CORP·Filed 2014·Granted Jun 9, 2015·6 cites·32 claims
- 2892US7323479B2Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindolineCELGENE CORP·Filed 2003·Granted Jan 29, 2008·36 cites·29 claims
- 2991US8623384B2Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of acute myelogenous leukemiaCELGENE CORP·Filed 2013·Granted Jan 7, 2014·9 cites·23 claims
- 3091US8440194B2Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemiasZELDIS JEROME B·Filed 2008·Granted May 14, 2013·9 cites·22 claims
- 3191US6486177B2Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidateCELGENE CORP·Filed 2001·Granted Nov 26, 2002·31 cites·46 claims
- 3290US9056103B2Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemiasCELGENE CORP·Filed 2013·Granted Jun 16, 2015·7 cites·26 claims
- 3390US8632787B2Methods using immunomodulatory compounds for treatment of certain leukemiasZELDIS JEROME B·Filed 2011·Granted Jan 21, 2014·8 cites·13 claims
- 3489US8404717B2Methods of treating myelodysplastic syndromes using lenalidomideZELDIS JEROME B·Filed 2011·Granted Mar 26, 2013·6 cites·10 claims
- 3588US9393238B2Methods for treating non-hodgkin's lymphoma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with a second active agentCELGENE CORP·Filed 2014·Granted Jul 19, 2016·3 cites·28 claims
- 3688US9155730B2Methods for treating non-hodgkin's lymphoma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a second active agentCELGENE CORP·Filed 2014·Granted Oct 13, 2015·3 cites·28 claims
- 3787US7325355B2Methods for treatment of atherosclerosis using 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindolineCELGENE CORP·Filed 2005·Granted Feb 5, 2008·7 cites·14 claims
- 3886US9498472B2Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemiasCELGENE CORP·Filed 2015·Granted Nov 22, 2016·3 cites·14 claims
- 3985US7563810B2Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseasesCELGENE CORP·Filed 2003·Granted Jul 21, 2009·17 cites·16 claims
- 4084US7182953B2Methods and compositions for the prevention and treatment of atherosclerosis restenosis and related disordersCELGENE CORP·Filed 2000·Granted Feb 27, 2007·14 cites·25 claims
- 4183US9925207B2Methods of treating myelodysplastic syndromes using lenalidomideCELGENE CORP·Filed 2014·Granted Mar 27, 2018·1 cites·32 claims
- 4283US7893045B2Methods for treating lymphomas in certain patient populations and screening patients for said therapyCELGENE CORP·Filed 2008·Granted Feb 22, 2011·5 cites·25 claims
- 4383US5922736AChronic, bolus administration of D-threo methylphenidateCELGENE CORP·Filed 1997·Granted Jul 13, 1999·34 cites·10 claims
- 4482US7435726B2Compositions and methods for the treatment of cancerCELGENE CORP·Filed 2001·Granted Oct 14, 2008·14 cites·10 claims
- 4582US5984887APhotopheresis treatment of leukocytesTHERAKOS INC·Filed 1997·Granted Nov 16, 1999·72 cites·9 claims
- 4678US2009088455A1Chronic, Bolus Adminstration Of D-Threo MethylphenidateCELGENE CORP·Filed 2008·Application pending·0 cites
- 4777US8404716B2Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidineZELDIS JEROME B·Filed 2010·Granted Mar 26, 2013·2 cites·37 claims
- 4877US2019175575A1Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseasesCELGENE CORP·Filed 2019·Application pending·0 cites
- 4976US7612096B2Methods for treatment, modification and management of radiculopathy using 1-oxo-2-(2,6-dioxopiperidin-3yl)-4-aminoisoindolineCELGENE CORP·Filed 2004·Granted Nov 3, 2009·9 cites·17 claims
- 5076US2010063094A1Methods for treatment of colorectal cancer using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dioneCELGENE CORP·Filed 2009·Application pending·0 cites
Showing the top 50 of 147 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jerome B. Zeldis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →